Xenon Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Xenon Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Xenon Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xenon Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.3M | 107k | 40.15 |
| 2025-06-30 | $4.8M | 153k | 31.30 |
| 2025-03-31 | $3.5M | 105k | 33.55 |
| 2024-12-31 | $263k | 6.7k | 39.20 |
| 2024-09-30 | $523k | 13k | 39.37 |
| 2024-06-30 | $490k | 13k | 38.99 |
| 2024-03-31 | $1.6M | 36k | 43.05 |
| 2023-12-31 | $1.4M | 31k | 46.06 |
| 2023-09-30 | $201k | 5.9k | 34.16 |
| 2023-06-30 | $189k | 4.9k | 38.67 |
| 2023-03-31 | $165k | 4.6k | 35.79 |
| 2022-12-31 | $184k | 4.7k | 39.43 |
| 2022-09-30 | $123k | 3.4k | 35.83 |
| 2022-06-30 | $76k | 2.5k | 30.83 |
| 2022-03-31 | $53k | 1.2k | 43.48 |
| 2021-12-31 | $56k | 1.8k | 31.51 |
| 2021-09-30 | $16k | 1.0k | 15.66 |
| 2021-06-30 | $19k | 1.0k | 18.61 |
| 2021-03-31 | $18k | 1.0k | 18.00 |
| 2020-12-31 | $27k | 1.7k | 15.53 |
| 2020-09-30 | $23k | 2.0k | 11.43 |
| 2020-06-30 | $30k | 2.3k | 13.00 |
| 2020-03-31 | $7.0k | 632 | 11.08 |
| 2019-12-31 | $23k | 1.8k | 13.12 |
| 2019-09-30 | $11k | 1.2k | 8.94 |
| 2019-06-30 | $51k | 5.1k | 10.00 |
| 2019-03-31 | $30k | 3.0k | 10.00 |
| 2018-12-31 | $999 | 149 | 6.71 |
| 2018-09-30 | $11k | 854 | 13.03 |
| 2018-06-30 | $8.0k | 889 | 9.00 |
| 2017-06-30 | $8.0k | 2.5k | 3.16 |
| 2016-09-30 | $5.0k | 617 | 8.10 |
| 2016-03-31 | $8.0k | 1.1k | 7.23 |
| 2015-12-31 | $21k | 2.6k | 7.99 |
| 2015-03-31 | $6.0k | 346 | 17.34 |